2 3 7 8-Tetrachlorodibenzo-P-Dioxin Aconitum Napel

證據等級: L5 預測適應症: 0

目錄

  1. 2 3 7 8-Tetrachlorodibenzo-P-Dioxin Aconitum Napel
  2. Multi-Substance Complex (TW-UNKNOWN-multi): Insufficient Data for Repurposing Evaluation
    1. One-Sentence Summary
    2. Quick Overview
    3. Why No Prediction Is Available
    4. Conclusion and Next Steps
    5. Disclaimer

## 藥師評估報告

Multi-Substance Complex (TW-UNKNOWN-multi): Insufficient Data for Repurposing Evaluation

One-Sentence Summary

This entry corresponds to a multi-substance identifier comprising 23 components — ranging from homeopathic botanicals (e.g., Arnica montana, Apis mellifera, Calendula) to industrial chemicals (e.g., benzene, dioxin, hydrogen cyanide) — that could not be resolved to a single drug entity. No original indication, no regulatory approval in Taiwan, and no TxGNN-predicted indications were returned. The evidence base is effectively empty (L5), and this entry cannot be meaningfully evaluated for drug repurposing at this time.


Quick Overview

Item Content
Original Indication None on record
Predicted New Indication None
TxGNN Prediction Score N/A
Evidence Level L5 (model prediction only — no prediction generated)
US Market Status Not marketed
Number of NDAs 0
Recommended Decision Hold

Why No Prediction Is Available

The drug INN field contains a semicolon-delimited list of 23 heterogeneous substances:

# Substance Category
1 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Industrial toxin / Environmental contaminant
2 Aconitum napellus whole Toxic botanical / Homeopathic ingredient
3 Ammonium cation Inorganic ion
4 Apis mellifera Homeopathic ingredient (bee venom)
5 Arnica montana whole Homeopathic botanical
6 Arsenic trioxide Approved anticancer agent (AML)
7 Benzene Industrial carcinogen
8 Calendula officinalis flowering top Homeopathic botanical
9 Chlorine Industrial chemical / Toxin
10 Chloroform Industrial solvent / Hepatotoxin
11 Dieffenbachia seguine whole Toxic plant
12 Fenson Obsolete acaricide / Pesticide
13 Fluorine Reactive element
14 Hydrogen cyanide Highly toxic gas
15 Methane Combustible gas
16 Nitric acid Strong acid
17 Onion Food / Homeopathic ingredient
18 Phosfolan Organophosphate pesticide
19 Potassium cyanide Highly toxic salt
20 Propane Combustible gas
21 Sulfur Mineral / Homeopathic ingredient
22 Sulfuric acid Strong acid
23 Veratrum album root Toxic botanical

This mixture of industrial chemicals, environmental toxins, pesticides, and homeopathic botanicals does not correspond to any identifiable single drug entity. The TxGNN pipeline requires a resolvable DrugBank ID to generate knowledge-graph embeddings; since drugbank_id is null and the INN string could not be mapped, no prediction was produced.

The most plausible data pipeline issue is that multiple FDA product ingredient lists were concatenated without deduplication, generating a meaningless compound key. The candidate ID TW-UNKNOWN-multi supports this hypothesis.


Conclusion and Next Steps

Decision: Hold

Rationale: This entry does not represent a real drug candidate. It is a pipeline artifact — a concatenated multi-ingredient string that failed to resolve to any single pharmacological entity — and cannot be assessed for repurposing potential.

To proceed, the following is needed:

  • Deduplication and parsing: Split the concatenated INN string at the source and create one candidate record per distinct active ingredient.
  • Identity resolution: Re-run DrugBank mapping on each individual substance (e.g., Arsenic trioxide → DB01169, which has known oncology use and may be a legitimate repurposing candidate).
  • Data provenance audit: Investigate why TW-UNKNOWN-multi was generated — likely a bug in the Taiwan FDA data ingestion step where a multi-ingredient product’s ingredient list was flattened into the INN field.
  • Exclusion of non-drug substances: Industrial chemicals (benzene, TCDD, HCN), gases (methane, propane), and strong acids (sulfuric acid, nitric acid) should be excluded from the repurposing pipeline entirely, as they have no therapeutic application.
  • Homeopathic ingredient handling: Substances such as Arnica montana, Calendula officinalis, and Apis mellifera may require a dedicated homeopathic product pipeline with separate evaluation criteria.

    Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.



Copyright © 2026 UsTxGNN Project. For research purposes only.

This site uses Just the Docs, a documentation theme for Jekyll.